ScreenerHero

QPT Quest PharmaTech Inc.

TSXV · CA · Healthcare · Biotechnology · questpharmatech.com
0.0300CAD0.00%Mkt Cap: 3.08M $P/E: 0.83

Quest PharmaTech Inc., a pharmaceutical company, develops targeted cancer therapies in Canada. Its lead product is MAb AR9.6, a theranostic agent for cancer in preclinical development for pancreatic cancer. The company i…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$127.54BUSDP/E 29.3
MRNA
Moderna, Inc.
$81.13BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$74.79BUSDP/E 18.0
ARGX
argenx SE
$57.11BUSDP/E 34.8
ARGX
argenx SE
$55.24BUSDP/E 36.1
RVMD
Revolution Medicines, Inc.
$44.51BUSD
UCB
UCB SA
$41.63BUSDP/E 17.7
ONC
BeOne Medicines AG
$41.14BUSDP/E 64.7
RPRX
Royalty Pharma plc
$32.74BUSDP/E 30.1
ALNY
Alnylam Pharmaceuticals, Inc.
$29.42BUSDP/E 37.1
ROIV
Roivant Sciences Ltd.
$25.84BUSD
BNTX
BioNTech SE
$24.53BUSD
GMAB
Genmab A/S
$24.01BUSDP/E 30.3
INCY
Incyte Corporation
$23.13BUSDP/E 14.5
INSM
Insmed Incorporated
$22.67BUSD
GMAB
Genmab A/S
$21.61BUSDP/E 29.3
JAZZ
Jazz Pharmaceuticals plc
$15.32BUSDP/E 16.2
ASND
Ascendis Pharma A/S
$15.01BUSDP/E 17.5
EXEL
Exelixis, Inc.
$14.58BUSDP/E 18.6
SMMT
Summit Therapeutics Inc.
$13.78BUSD

Key Statistics

Company
Market Cap3.08M USD
Enterprise Value3.75M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)3.64M USD
Revenue/Share—
Last Price0.0300 CAD
Fiscal Year EndJan 2026
MR QuarterJul 2026
Employees—
CountryCA
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)0.83
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.16
EPS (TTM)0.03
EPS (Forward)—
52W Range
0.020033% of range0.0500
52W High0.0500 CAD
52W Low0.0200 CAD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE18.91%
ROA18.01%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-138.90K USD
CapEx (TTM)—
FCF Margin—
FCF Yield-1.14%
Net Debt667.93K USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.04
Current Ratio0.06
Quick Ratio0.06
Book Value/Sh0.16 CAD
Cash/Share0.00 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 CAD
Div. Yield0.00%
5Y Avg Yield42.21%
Payout Ratio0.00%
Ex-Div DateJul 21, 2005
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.169.13M
Float138.75M
Insiders16.88%
Institutions0.00%
Short Interest
Short Ratio0.6d
Short % Out.0.00%
Shares Short541
Short (prev mo.)3.01K
Technical
SMA 500.0240 (+25.0%)
SMA 2000.0321 (-6.4%)
Beta-0.31
S&P 52W Chg14.58%
Avg Vol (30d)6.25K
Avg Vol (10d)1.60K
Technical Indicators
RSI (14)66.5
MACD0.0020
MACD Signal0.0014
MACD Hist.+0.0006
BB Upper0.0357 CAD
BB Middle0.0255 CAD
BB Lower0.0153 CAD
BB Width80.07%
ATR (14)0.0009 CAD
Vol Ratio (20d)0.00x